top of page
logo_3 (2).png

PRESS

PRESS RELEASES

Strategy, judges and three key minutes: Xeptiva Therapeutics at South Summit Brazil 2026
Xeptiva Therapeutics has been selected as a finalist to pitch at the South Summit Brazil 2026 Startup Competition
Athos Therapeutics and Xeptiva Therapeutics announce partnership to discover vaccine biomarkers
Xeptiva: Uruguayan biotechnology startup
Uruguayan scientists create a vaccine to treat chronic pain in dogs
The Uruguayan Biotech Startup that caught the interest of the four largest laboratories in the world
Uruguayan scientists are testing a vaccine against osteoarthritis in dogs and are looking for volunteers for trials
Up to 80% of dogs over the age of 9-10 years may suffer from chronic osteoarthritis pain
Felipe's Story
Osteoarticular vaccine for dogs
Emiliano Trias, CSO, talks about Xeptiva's story
Uruguayan scientists advance in research on chronic pain in dogs
Polo's Story
Dr. Nadia Crosignani talks about Xeptiva's clinical trial 
How is the first therapeutic vaccine entirely developed in Uruguay?
Frodo's Story
Josefina Correa, CEO of Xeptiva, wins the first prize at the VC Latam Summit Miami 2025
Vaccine to treat chronic pain in animals
Locos por las Mascotas & Xeptiva Therapeutics Interview
20% of adult dogs may suffer from chronic pain
Meet the story of Felipe! One of the dogs participating in the clinical trial
Vaccine against pain in dogs
First chronic pain vaccine is developed by Xeptiva Therapeutics
Uruguayan researchers and veterinarians are seeking to test the first vaccine against chronic pain in dogs
A team of professionals created a biotechnology venture that developed an innovative treatment for dogs
Uruguayan scientists develop the first vaccine for chronic pain in dogs
Uruguayan biotech startup develops vaccines to reliev chronic pain in companion animals
Vaccine who treats chronic pain in dogs
Xeptiva contributes to the growth of the Uruguayan scientific ecosystem
Scientists develop a vaccine for chronic pain in companion animals
Vaccine against chronic pain in animals
Uruguayan scientists developed a vaccine from synthetically designed proteins
Vaccine for chronic pain in companion animals shows promise in early trials
Uruguayan scientists developed the first vaccine for chronic pain in dogs and cats
Xeptiva moves closer to first vaccine for chronic pain in companion animals
Everything about Xeptiva Therapeutics
Josefina Correa (CEO) and Emiliano Trias (CSO) discussed about the biotech ecosystem in Uruguay and Xeptiva's technology
Veterinary School in Uruguay is looking for dogs with chronic pain for an experimental vaccine study.
Uruguayan scientists develop vaccine for chronic pain
Vaccines to alleviate chronic pain in pets
The Institut Pasteur and the start-up Xeptiva Therapeutics have developed a vaccine to treat pain in pets
Sergio Fogel will invest millions in a company run by two young Uruguayans
Entrepreneurships with sustainable DNA, four young people who opted for triple impact
Time to become an investment magnet
A Uruguayan start-up advances in therapy to block pain in dogs, cats and horses
bottom of page